Stem cell therapy isn’t FDA approved for any cause of peripheral neuropathy, and the evidence is even more limited than it is for joint injections. Still, clinics market it as a treatment for nerve pain and numbness in the hands and feet, especially when linked to diabetes. This guide breaks down the cost, what the research actually shows, and which proven options are worth trying first.
What neuropathy is, and why stem cells get marketed for it
Peripheral neuropathy is nerve damage that causes pain, tingling, numbness, or weakness, usually starting in the feet and hands. Diabetes is by far the most common cause in the US, though chemotherapy, autoimmune conditions, and unexplained (idiopathic) cases account for a meaningful share too. Because damaged nerves have limited ability to regenerate on their own, and because standard treatments mostly manage symptoms rather than reverse the underlying nerve damage, neuropathy is exactly the kind of frustrating, hard-to-fix condition where regenerative-medicine marketing tends to concentrate.
What clinics inject and how
Protocols vary, but most clinics use mesenchymal stem cells sourced from your own bone marrow or fat, or occasionally donor tissue, injected or infused near the affected nerves or given intravenously. The stated goal is to calm nerve inflammation and support nerve repair, though — as with other unapproved uses — no product is standardized or FDA-cleared for this purpose.
What the evidence shows
The evidence for stem cell therapy in neuropathy is thin, and what exists focuses mostly on diabetic peripheral neuropathy rather than neuropathy generally. A 2024 systematic review screened more than 5,000 studies and found only seven controlled human trials worth analyzing for diabetic peripheral neuropathy specifically. Those trials reported improvements in nerve conduction velocity — a measure of how well electrical signals travel along the nerve — but the review flagged a lack of long-term safety data and inconsistent treatment protocols across studies, meaning the results are not yet reliable enough to draw firm conclusions.
A separate 2025 case series following patients with peripheral nerve injury reported no objective functional improvement at long-term follow-up, with the researchers explicitly describing stem cell therapy for peripheral nerve injury as still experimental. Put together, the honest read is: some small studies show a signal worth studying further, but nothing rises yet to the level of proven benefit you could rely on for a treatment decision.
Current evidence does not show that stem cell therapy reverses existing nerve damage. The reviewed trials measured nerve conduction changes. None demonstrated tissue regeneration.
What it costs
Reported prices for stem cell neuropathy treatment in the US commonly run from several thousand dollars to $20,000 or more, varying by the number of limbs treated, the cell source, and whether the clinic recommends more than one round. Because no approved protocol exists, there is no standard price to check a quote against, and refund policies if the treatment does not help are rare.
Insurance, Medicare, and Medicaid do not cover stem cell injections for neuropathy of any cause, since none carry FDA approval. You pay the full amount yourself regardless of outcome.
Proven treatments to try first
For diabetic neuropathy specifically, the best-evidenced step is tighter blood sugar control, which can slow nerve damage progression, alongside FDA-approved medications such as gabapentin, pregabalin, and duloxetine for symptom relief. Physical therapy helps some patients maintain function and reduce fall risk. For more severe, treatment-resistant pain, spinal cord stimulation is an established option with a far larger evidence base than any stem cell protocol.
| Option | Typical cost | Insurance? | Evidence for neuropathy |
|---|---|---|---|
| Blood sugar control + medication (gabapentin, pregabalin, duloxetine) | Often low with insurance | Usually yes | Established, first-line |
| Physical therapy | $50 – $150 / visit | Often yes | Supportive, well studied |
| Spinal cord stimulation | $30,000 – $50,000+ (often insurance-covered when approved) | Case by case | Established for severe, resistant pain |
| Stem cell injection | $5,000 – $20,000+ | No | Limited — 7 controlled trials reviewed as of 2024 |
Questions to ask before you consider it
- What specific type of neuropathy does the clinic’s cited research actually cover? Most available data is for diabetic peripheral neuropathy; a clinic treating chemotherapy-induced or idiopathic neuropathy the same way is extrapolating beyond its own evidence.
- Have you tried, and given a fair trial to, the FDA-approved medications and blood-sugar management first? These have far more evidence and are usually cheaper and insurance-covered.
- What does the clinic say happens if nerve conduction testing shows no improvement? A clear, honest answer is a better sign than a guarantee.
Before paying a deposit anywhere, read our clinic red-flag checklist, which applies to neuropathy clinics as much as any other regenerative-medicine offer.
The bottom line
Stem cell therapy for neuropathy is not FDA approved for any cause, and the strongest available human trial evidence — seven controlled studies for diabetic peripheral neuropathy as of a 2024 review — shows a modest, unproven signal rather than established benefit. It typically costs $5,000 to $20,000 or more, self-pay, with no standardized protocol. Exhaust the proven medication and blood-sugar options first, and read any clinic’s specific evidence claims against what the actual published research covers.
Frequently asked questions
Is stem cell therapy FDA approved for neuropathy?
No. The FDA has not approved any stem cell product for peripheral neuropathy of any cause, diabetic or otherwise. Clinics offering it operate outside FDA approval, so you pay entirely out of pocket.
Does stem cell therapy work for neuropathy?
The evidence is thin. A 2024 systematic review of stem cell therapy for diabetic peripheral neuropathy found only seven controlled human trials worth including, out of over 5,000 studies initially screened. Those trials reported improved nerve conduction test results, but lacked long-term safety data and used inconsistent methods, so no strong conclusion can be drawn yet.
How much does stem cell therapy for neuropathy cost?
Reported prices for stem cell neuropathy injections in the US commonly run from several thousand dollars to $20,000 or more, depending on the cell source, how many limbs are treated, and whether multiple sessions are recommended. Pricing is not standardized because no approved protocol exists to price against.
What causes peripheral neuropathy, and does the cause matter for treatment?
Diabetes is the most common cause of peripheral neuropathy in the US, followed by chemotherapy, autoimmune disease, and unknown (idiopathic) causes. Most stem cell neuropathy research focuses on diabetic peripheral neuropathy specifically, so evidence for other causes is thinner still. Ask any clinic what type of neuropathy their published data actually covers.
What are proven treatments for peripheral neuropathy?
Strict blood sugar control combined with first-line medications including gabapentin, pregabalin, and duloxetine is the best-evidenced starting point for diabetic neuropathy. For severe, treatment-resistant pain, spinal cord stimulation is the most-evidenced option. Physical therapy serves as a supportive option to improve balance, strength, and mobility.
What are the risks of a stem cell injection for neuropathy?
Reported risks include pain, swelling, or bruising at the injection site, infection, and — since some protocols inject near nerves directly — a small risk of nerve irritation or new numbness from the needle itself. Because sourcing and processing vary by clinic, quality and risk vary along with them.
How long before a stem cell injection shows any effect on neuropathy pain?
No standardized timeline has been established in available trials for when stem cell injections affect neuropathy pain. Published studies have focused on measuring nerve conduction changes over time instead of reporting a fixed window for symptom relief.
How long do the effects of a stem cell neuropathy treatment last, and will I need repeat injections?
There is no published clinical data on how long stem cell therapy for neuropathy lasts or how often patients need repeat injections. Because trials have not tracked long-term durability, ask the clinic directly what happens if any initial pain relief fades. Find out in advance whether their protocol recommends repeat rounds and how much those added procedures cost.
Is stem cell therapy for optic neuropathy the same as what this page covers?
No. Optic neuropathy is damage to the optic nerve, which carries visual signals from the eye to the brain. That is a different condition from peripheral neuropathy, the nerve damage in the hands and feet described above. No stem cell product is approved by the Food and Drug Administration (FDA) for optic neuropathy of any cause. ClinicalTrials.gov lists registered, investigational studies evaluating regenerative approaches for optic nerve conditions, but this early-stage research does not establish proven benefit. A reader whose primary concern is vision loss or optic nerve damage should consult an ophthalmologist or check the National Eye Institute (NEI) rather than a general regenerative-medicine clinic.
Medical disclaimer. Medical Frontier is an independent educational resource. This page is for general information only and is not medical advice, diagnosis, or treatment, and does not create a doctor–patient relationship. Most regenerative therapies discussed here are not FDA-approved for the uses described and may be offered under limited exemptions or in clinical trials only. Always consult a licensed physician before making any treatment decision.